Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Join the club for FREE to access the whole archive and other member benefits.
Company focused on the development of telomerase therapy to treat Alzheimer's disease.
Telocyte™ focuses on curing Alzheimer’s disease. Telocyte™ plans to run FDA-sponsored human trials to reverse Alzheimer’s pathology at the cellular level. Currently, there are no effective medical or pharmaceutical interventions for those suffering from Alzheimer’s disease.
We have the technology (animal trials have already proven effective), the support, and the clinical experience to begin the first-in-human trials of an effective clinical cure for Alzheimer’s.
Our mission is not to help anyone “live with Alzheimer’s”, but to ensure that all of us can live without Alzheimer’s. Our mission is to cure Alzheimer’s, plain and simple. We intend to save the lives, the minds, and the presence of those who have Alzheimer’s now and to prevent anyone from getting Alzheimer’s in the future.
Our mission is to bring that future into the present. We are dedicated to helping those who have lost hope and giving hope to those who need it.
Visit website: https://telocyte.com/
Details last updated 08-Jan-2021
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
The researchers will not only focus on CVD or cellular aging but the optimal point of intervention